Skip to main content
. 2014 Jun 19;9(6):e100547. doi: 10.1371/journal.pone.0100547

Figure 5. Testing for dose equivalence between BB and MRT by xCELLigence assays.

Figure 5

Comparison of cell proliferation response by xCELLigence assays of (A) EMT6.5ch tumour, (B) 4T1Ch5 tumour and (C) SaOS-2 tumour cells following MRT 175/25 or synchrotron BB irradiation at equivalent doses. Data are represented as mean ± SEM (n = 3); *p<0.05. EMT6.5ch–mouse mammary tumour cells, 4T1Ch5–mouse mammary tumour cells, SaOS-2–osteocarcinoma cells.